Actualités Fennec Pharmaceuticals Inc - FENC | Actions NASDAQ | ADVFN

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Fennec Pharmaceuticals Inc (FENC)
Fennec Pharmaceuticals Inc (FENC) Actualités

Fennec Pharmaceuticals Inc (FENC)

6,40

0,29

(4,75%)

Fermé 11 Mars 9:00PM

Retardé de 15 minutes

6,40

0,00

( 0,00% )

Avant marché: 9:00AM

Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025

RESEARCH TRIANGLE PARK, N.C., March 06, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC;...

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany

~ PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Fennec Pharmaceuticals

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales